If you are an IMG who was ever told to build your CV around research volume, you built it in good faith, because for years, volume was the strategy that worked. That strategy just stopped working, and almost nobody is telling international graduates why it matters specifically to them.
For the 2027 ERAS season, the AAMC replaced the long-standing Publications section with a new section called Scholarly Work. Most of the coverage of this change has focused on U.S. medical students: how it affects their research timelines, their advisor conversations, their CVs. What almost nobody has written about is what this change does to the specific strategy that IMGs have been coached into for the better part of a decade, often by the very companies claiming to help them.
The Strategy This Was Built Around
Here is the reality of how IMG applications have been built for years. Without a U.S. medical degree to point to, and with Step 1 now pass/fail, research volume became one of the few objectively comparable numbers an IMG could put next to a U.S. graduate's application. So IMGs were told, again and again, to maximize that number. Get on as many projects as possible. Turn one piece of work into an abstract, a poster, an oral presentation, and eventually a manuscript, so that one research effort could appear as three or four separate lines on the old Publications section. A long list read as productivity, and productivity read as competitiveness.
It is not a coincidence that when we talk about candidates who eventually placed successfully, research experience shows up as a credential worth naming specifically. It became the differentiator IMGs were told they could control when so much else in the process felt outside their control.
What Actually Changed
The new Scholarly Work section is built around a different premise entirely. Instead of listing every version of a research effort as a separate entry, applicants are now expected to group genuinely related outputs together as a single collection. The abstract, the poster, and the oral presentation from one project are no longer three lines — they are one, presented together as what they actually are: one body of work. First authorship is now visible directly in the application rather than something a reviewer has to dig for. And applicants can flag only three entries as their most meaningful contributions, which forces a choice that a long, undifferentiated list was designed to avoid.
None of this is a cosmetic redesign. It is a structural rejection of the volume strategy itself.
Why This Hits IMGs Differently
A U.S. senior with six months of dedicated research time and two genuine projects loses very little in this change. Their application was never built around inflating a list.
An IMG who was coached to split every project into as many entries as possible, across multiple institutions, sometimes with limited depth in any single one, loses something real. The same CV that used to read as impressively productive now reads as diffuse. Reviewers can see the collections. They can see when three entries collapse into one underlying project. What once looked like breadth can now look like an absence of depth, in a format specifically designed to make that visible.
This is not a hypothetical risk. The AAMC's own program director survey data from 2024 already showed that more than seventy percent of program directors considered the raw number of publications not important or only somewhat important in interview decisions. The volume strategy was already delivering less than IMGs were led to believe. This season's redesign simply removed the format that let volume disguise itself as substance.
The Flip Side
There is a real opportunity in this change for the IMGs who did the opposite. If you spent a year in a sustained research role, went deep on one or two projects, and can point to first authorship and a clear, specific contribution, your application now looks stronger than it would have last cycle, not weaker. The section is finally built to reward exactly that kind of profile, and to stop rewarding its opposite.
If your research history looks more like the first description than the second, this is the season to be honest with yourself about it, and to build the rest of your application — your personal statement, your U.S. clinical experience, your letters — in a way that compensates deliberately rather than hoping volume will do the work it no longer can.
What To Do With This Now
Go back through your research history and identify which entries actually belong together as a single body of work. Do not force unrelated projects into a collection just to make the section look fuller, but do not list derivative outputs from one project as though they are three separate achievements either. Decide now which three contributions you would flag as most meaningful, and make sure your personal statement and letters can speak to those specific three in detail — because reviewers will now expect that you can.
If your instinct is to feel like the rules changed on you unfairly, that instinct is worth sitting with for a moment, and then setting aside. The applicants who adjust their strategy this season are the ones who will benefit from a change that was, in the end, always going to happen eventually.
If you want an honest read on how your research background actually looks under this new structure, that is the conversation we are here to have.